Related Experiment Video
Updated: Jul 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Measles vaccine failure
Abstract:
Suleimania Children's Hospital, Riyadh, Saudi Arabia was the site of a on-year study, started June 1987, which was designed to investigate measles vaccine failure. The first part of the study consisted of 336 patients with measles. Diagnosis was established on clinical grounds and confirmed by fluorescent IgM analysis. Those patients 9 months and older, which is the legal age of vaccination, comprised 310 subjects. Of these, 29.4% had been vaccinated. This percentage appears to be within the normal range, considering the local coverage rate of vaccination and seroconversion rate, compared with those for other countries. The main cause of vaccine failure was persistent maternal antibodies. The second part from various study involved testing the potency of some samples of measles vaccine obtained from various health centers in the Riyadh region. Potency was found to meet recommended standards.
Insights
Measles vaccine failure in Riyadh was mainly due to maternal antibodies. A study found measles vaccines met potency standards, indicating effective immunization programs are crucial for disease prevention.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Measles remains a significant public health concern globally.
- Vaccine failure can hinder eradication efforts.
- Understanding reasons for vaccine failure is critical for public health strategies.
Purpose of the Study:
- To investigate the causes of measles vaccine failure in children.
- To assess the potency of measles vaccine samples in the Riyadh region.
Main Methods:
- Clinical diagnosis of measles confirmed by fluorescent IgM analysis.
- Analysis of vaccination status in children aged 9 months and older.
- Potency testing of measles vaccine samples from local health centers.
Main Results:
- Persistent maternal antibodies were identified as the primary cause of measles vaccine failure.
- 29.4% of vaccinated measles patients were aged 9 months or older.
- Tested measles vaccine samples met recommended potency standards.
Conclusions:
- Persistent maternal antibodies significantly contribute to measles vaccine failure.
- The measles vaccines used in the Riyadh region meet quality standards.
- Public health strategies should consider maternal antibody interference in vaccination schedules.
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Poliomyelitis
Smallpox
Vaccines
Rocky Mountain Spotted Fever

